BSX — Boston Scientific Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapHigh Flyer

Annual balance sheet for Boston Scientific, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	217	1,734	1,925	928	865
Net Total Accounts Receivable
Net Total Receivables	1,828	1,531	1,778	1,970	2,228
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	4,699	6,694	6,317	5,760	6,514
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2,415	2,542	2,687	2,832	3,298
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	30,565	30,777	32,229	32,469	35,136
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	4,866	3,681	4,274	3,803	4,933
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	16,688	15,451	15,607	14,896	15,854
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	13,877	15,326	16,622	17,573	19,282
Total Liabilities & Shareholders' Equity	30,565	30,777	32,229	32,469	35,136
Total Common Shares Outstanding